Blocked NLD massage, Baby having tears, blocked nasal / tear duct - how to massage baby's eyes Blocked NLD massage, Baby having tears, blocked nasal / tear duct - how to massage baby's eyes

Blocked NLD massage, Baby having tears, blocked nasal / tear duct - how to massage baby's eyes, as suggested by a Pediatrician and Ophthalmologist (Eye doctor) as well. https://youtu.be/Kb2k9WKup_s Charak Child Care

Blocked NLD massage, Baby having tears, blocked nasal / tear duct - how to massage baby's eyes

via IFTTT

A new drug may help treat Ebola, Yellow Fever & even ZIKA virus

A Durham pharmaceutical company has received $3.5 million from a federal agency to support clinical trials for a drug to treat people with yellow fever.

For BioCryst Pharmaceuticals, the latest funds from the National Institute of Allergy and Infectious Diseases (NIAID) for galidesivir brings development contract funding to a total of $43 million.  

BioCryst saw success during its Phase 1 trials; healthy patients tolerated the drug and found it to be safe. In animal studies, galidesivir showed benefits against several viruses, including Ebola, yellow fever and Zika.

Severe cases of yellow fever lead to fatal heart, liver and kidney conditions. The disease is particularly serious in tropical areas of Africa and Central and South America, responsible for 170,000 severe cases and up to 60,000 deaths annually, according to the World Health Organization. Currently, there is no approved treatment for the disease. 

Brazil in particular faces serious issues with the disease. Seasonal outbreaks have put more than 35 million people at risk, and the Brazilian Ministry of Health has confirmed 2,043 cases and 676 deaths from yellow fever since December 2016. 

The galidesivir development program project has been funded by the NIAID – part of the National Institutes of Health – and Biomedical Advanced Research and Development Authority, which is part of the Department of Health and Human Service’s Office of the Assistant Secretary for Preparedness Response.  

Concerns about 'tainted' Oral Polio Vaccine in India - how bad is the situation for an individual parent?

MUMBAI (Reuters) - The World Health Organization (WHO) said on Monday that there was minimal risk of children contracting the polio virus in India from a tainted batch of vaccines.

The public health scare, which potentially affected thousands of children, put a renewed spotlight on lax pharmaceutical quality control procedures in India.

The latest concerns emerged over the weekend after vaccines produced by privately-held Bio-Med Pvt Ltd and distributed as part of a free government drive to eradicate polio were found to have a strain of the virus that had been eradicated around the world and phased out of vaccines.

However Shamila Sharma, a spokeswoman for the WHO, said any risk to children was "minimal" due to the high routine polio immunization coverage in India. The WHO funds and supports India's polio-control program.

Health officials in New Delhi said they were investigating why and how Bio-Med was still producing such vaccines, and that the affected lots were being recalled. The Indian government had ordered this type of vaccine to be discontinued in 2016.

Local media reported on the weekend that police arrested the managing director of the northern India-based Bio-Med Pvt Ltd, after routine testing revealed it had made and shipped some 150,000 lots of oral polio vaccines that contained the type 2 polio vaccine virus.

India, often dubbed the pharmacy of the world, is home to thousands of factories churning out drugs and vaccines for sale globally, but local regulation is lax. In recent years, U.S. and European regulators have slammed many Indian drug factories for faulty manufacturing practices, often issuing warnings or bans.

"We don't have good quality control mechanisms," said Oommen Kurian, a health researcher at New Delhi-based Observer Research Foundation, adding the country also doesn't have the capacity to implement regulation.

Bio-Med and India's top drugs regulator, the Central Drug Standard Control Organization, did not respond to requests for comment on Monday.

Some batches of typhoid vaccines produced by Bio-Med were also found to be "not-of standard quality" by the CDSCO earlier this year, according to a public notice by the agency dated March 14, 2018.

Reuters Health Information © 2018 

Cite this article: WHO Plays Down Risk to Indian Children From Tainted Polio Vaccine - Medscape - Oct 01, 2018.

Source

My take on this: 

What all this basically means is the following

1. One company supplying to the govt has been found to be making vaccine that is the same as what was being given to all children before 2016 - for example my daughter got this vaccine when she was a child.

2. This is NOT a cause of significant concern for any child who has received IPV (Injectable Polio vaccine) OR for any child who has received the 'contaminated' vaccine as well.

Why the govt is concerned is for a different reason - it can lead to the spread of the virus in the community - but this would NOT be very relevant to any child who has taken the 'contaminated' vaccine & especially if they have taken the IPV as well.

Reuters Health Information © 2018 

Cite this article: WHO Plays Down Risk to Indian Children From Tainted Polio Vaccine - Medscape - Oct 01, 2018.

Source